Partnerships
Partnerships
At OssiFi we are constantly searching for synergistic partnerships with like-minded companies as a way to build shareholder value and share risk. We believe that through these partnerships significant value can be generated while simultaneously solving healthcare issues associated with the sclerostin pathway; including osteoporosis and other related diseases.
When you partner with OssiFi, you gain significant experience, dedication and commitment from a biopharmaceutical organization focused on developing meaningful treatments to allow patients to lead healthier and higher quality lives.
We are actively seeking new development opportunities.
If you have an interest in collaborating with our team, please use this link.
-
![]()
Corporate Development
ButtonPrivately held company. Since its inception, it has been capitalized using convertible notes, non-dilutive grants, and equity.
-
![]()
Professionals
ButtonOssiFi is developing best in class sclerostin small molecule inhibitors to take advantage of new opportunities to develop safer, more effective bone building therapies.
-
![]()
Distribution List
ButtonSign up to keep updated on OssiFi news.
-
![]()
Careers
ButtonOssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation.
ABOUT US
OssiFi Therapeutics is an innovative bone-biology company operating at the intersection of therapeutics and medical devices to address significant unmet needs in neurogenic low back pain, fracture repair, and fracture prevention.